ELV - Company ID 0001156039
The table below shows Elevance Health, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $199.13B | $177.01B | $171.34B | $156.59B | $138.64B | $121.87B |
| Cost of revenue | $21.18B | $19.75B | $17.29B | $13.04B | $10.89B | $8.95B |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A |
Elevance Health, Inc. reported annual revenue of $199.13B for fiscal year 2025. That is up 12.5% from $177.01B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $84.86B (FY 2016) to $199.13B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $20.98B |
| $20.02B |
| $20.09B |
| $17.70B |
| $15.92B |
| $17.45B |
| Operating income | $7.20B | $7.86B | $8.50B | $8.28B | $7.56B | $6.36B |
| Income tax | $1.05B | $1.93B | $1.72B | $1.71B | $1.85B | $1.67B |
| Net income | $5.66B | $5.98B | $5.99B | $5.89B | $6.16B | $4.57B |
| EPS (diluted) | $25.21 | $25.68 | $25.22 | $24.28 | $24.95 | $17.98 |